Featured News

FDA Warns About New Impulse-Control Problems With Aripiprazole 05/04/2016

FDA Warns About New Impulse-Control Problems With Aripiprazole

The U.S. Food and Drug Administration (FDA) is warning that compulsive or uncontrollable urges to gamble, binge eat, shop, and have sex have been reported with the use of the antipsychotic drug aripiprazole (Abilify, Abilify Maintena, Aristada, and generics). These uncontrollable urges were reported to have stopped when the medicine was discontinued or the dose was reduced.More »

Advertisement
Syndicate content